British Journal of Dermatology

ISSN 0007-0963, Online ISSN: 0366-077X

Related content

By this: publisher
In this subject: Dermatology

Volume 153, Number 5, November 2005

The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis
pp. 869-873(5)
Authors: Warren, R.B.; Griffiths, C.E.M.

The new World Health Organization–European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants
pp. 874-880(7)
Author: Slater, D.N.

Early epidermal response after a single dose of -rays in organotypic culture of human breast skin
pp. 881-886(6)
Authors: Donetti, E.; Bedoni, M.; Boschini, E.; Bertelli, A.A.E.; Sforza, C.; Gagliano, N.

Differential expression of angiotensin receptors in human cutaneous wound healing
pp. 887-893(7)
Authors: Steckelings, U.M.; Henz, B.M.; Wiehstutz, S.; Unger, T.; Artuc, M.

Expression of haptoglobin in human keratinocytes and Langerhans cells
pp. 894-899(6)
Authors: Wang, H.; Gao, X-H.; Wang, Y-K.; Li, P.; He, C-D.; Xie, Y.; Chen, H-D.

Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis
pp. 900-910(11)
Authors: Ho, C.K.; Li, G.

The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis
pp. 911-918(8)
Authors: Otkjaer, K.; Kragballe, K.; Funding, A.T.; Clausen, J.T.; Noerby, P.L.; Steiniche, T.; Iversen, L.

Does facial sebum excretion really affect the development of acne?
pp. 919-924(6)
Authors: Youn, S-W.; Park, E-S.; Lee, D-H.; Huh, C-H.; Park, K-C.

Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma
pp. 925-931(7)
Authors: Richtig, E.; Ludwig, R.; Kerl, H.; Smolle, J.

Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans
pp. 932-936(5)
Authors: Martin, L.; Piette, F.; Blanc, P.; Mortier, L.; Avril, M-F.; Delaunay, M.M.; Dréno, B.; Granel, F.; Mantoux, F.; Aubin, F.; Sassolas, B.; Adamski, H.; Dalac, S.; Pauwels, C.; Dompmartin, A.; Lok, C.; Estève, E.; Guillot, B.

A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir
pp. 937-944(8)
Authors: Caspary, F.; Elliott, G.; Navé, B.T.; Verzaal, P.; Rohrbach, M.; Das, P.K.; Nagelkerken, L.; Nieland, J.D.

The tumour necrosis factor- inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques
pp. 945-953(9)
Authors: Gordon, K.B.; Bonish, B.K.; Patel, T.; Leonardi, C.L.; Nickoloff, B.J.

A study of natural rubber latex allergens in gloves used by healthcare workers in Singapore
pp. 954-959(6)
Authors: Koh, D.; Ng, V.; Leow, Y-H.; Goh, C.L.

Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis
pp. 960-966(7)
Authors: Taibjee, S.M.; Cheung, S-T.; Laube, S.; Lanigan, S.W.

A prospective study of the incidence of complications associated with dermatological surgery
pp. 967-971(5)
Authors: Amici, J.M.; Rogues, A.M.; Lasheras, A.; Gachie, J.P.; Guillot, P.; Beylot, C.; Thomas, L.; Taïeb, A.

Treatment of digital myxoid cysts with infrared coagulation: a retrospective case series
pp. 972-975(4)
Authors: Lonsdale-Eccles, A.A.; Langtry, J.A.A.

Large haematoxylin-stainable keratohyaline granules in solar keratoses: immunohistochemical comparison using anti-Ted-H-1 antibody and antiloricrin antibody
pp. 976-980(5)
Authors: Takahashi, M.; Horiuchi, Y.; Tezuka, T.

The role of CD4 and CD8 cytotoxic T lymphocytes in the formation of viral vesicles
pp. 981-986(6)
Authors: Morizane, S.; Suzuki, D.; Tsuji, K.; Oono, T.; Iwatsuki, K.

p53-specific CD8+ T-cell responses in individuals with cutaneous squamous cell carcinoma
pp. 987-991(5)
Authors: Black, A.P.; Bailey, A.; Jones, L.; Turner, R.J.; Hollowood, K.; Ogg, G.S.

An analysis of the skin care patient mix attending a primary care-based nurse-led NHS Walk-in Centre
pp. 992-996(5)
Authors: Ersser, S.J.; Lattimer, V.; Surridge, H.; Brooke, S.

Does enough quality of life-related discussion occur during dermatology outpatient consultations?
pp. 997-1000(4)
Authors: David, S.E.; Ahmed, Z.; Salek, M.S.; Finlay, A.Y.

Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo
pp. 1001-1010(10)
Authors: Finlan, L.E.; Kernohan, N.M.; Thomson, G.; Beattie, P.E.; Hupp, T.R.; Ibbotson, S.H.

Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA
pp. 1011-1015(5)
Authors: Wenzel, J.; Uerlich, M.; Wörrenkämper, E.; Freutel, S.; Bieber, T.; Tüting, T.

Familial brachioradial pruritus
pp. 1016-1018(3)
Authors: Wallengren, J.; Dahlbäck, K.

A novel mutation of the extracellular matrix protein 1 gene (ECM1) in a patient with lipoid proteinosis (Urbach–Wiethe disease) from Sicily
pp. 1019-1022(4)
Authors: Lupo, I.; Cefalu, A.B.; Bongiorno, M.R.; Daniele, O.; Valenti, V.; Noto, D.; Camarda, R.; Savettieri, G.; Aricò, M.; Averna, M.R.

Could proximal white subungual onychomycosis be a complication of systemic spread? The lessons to be learned from Maladie Dermatophytique and other deep infections
pp. 1023-1025(3)
Authors: Baran, R.; McLoone, N.; Hay, R.J.

Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules
pp. 1026-1030(5)
Authors: Shimomura, Y.; Sato, N.; Kariya, N.; Takatsuka, S.; Ito, M.

Multimodal in vivo optical imaging, including confocal microscopy, facilitates presurgical margin mapping for clinically complex lentigo maligna melanoma
pp. 1031-1036(6)
Authors: Chen, C-S.J.; Elias, M.; Busam, K.; Rajadhyaksha, M.; Marghoob, A.A.

Cutaneous IgA-associated vasculitis induced by alcohol
pp. 1037-1040(4)
Authors: Chua, I.C.; Aldridge, C.R.; Finlay, A.Y.; Williams, P.E.

Primary cutaneous CD30+ T-cell lymphoproliferative disorder following cardiac transplantation in a 15-year-old boy with Netherton's syndrome
pp. 1041-1046(6)
Authors: Katugampola, R.P.; Finlay, A.Y.; Harper, J.I.; Dojcinov, S.; Maughan, T.S.

Cutaneous infection with Alternaria tenuissima in an immunocompromised patient
pp. 1047-1049(3)
Authors: Robertshaw, H.; Higgins, E.

A case of linear IgA disease occurring in a patient with colonic Crohn's disease
pp. 1050-1052(3)
Authors: Birnie, A.J.; Perkins, W.

Small facial haemangioma and supraumbilical raphe—a forme fruste of PHACES syndrome?
pp. 1053-1057(5)
Authors: Chan, Y-C.; Eichenfield, L.F.; Malchiodi, J.; Friedlander, S.F.

Transient bullous dermolysis of the newborn in three generations
pp. 1058-1063(6)
Authors: Fassihi, H.; Diba, V.C.; Wessagowit, V.; Dopping-Hepenstal, P.J.C.; Jones, C.A.; Burrows, N.P.; McGrath, J.A.

A novel deletion mutation of the DSRAD gene in a Taiwanese patient with dyschromatosis symmetrica hereditaria
pp. 1064-1066(3)
Authors: Chao, S-C.; Lee, J.Y-Y.; Sheu, H-M.; Yang, M-H.

Topical pimecrolimus: a novel therapeutic option for Netherton syndrome
pp. 1067-1068(2)

Cryptococcal cellulitis in a lung-transplant recipient
pp. 1068-1070(3)

Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection
pp. 1070-1072(3)

A Korean case of oculocutaneous albinism type IV caused by a D157N mutation in the MATP gene
pp. 1072-1072(1)

A Korean case of oculocutaneous albinism type IV caused by a D157N mutation in the MATP gene: reply from authors
pp. 1073-1073(1)

Infliximab treatment for severe orogenital ulceration in Behçet's disease
pp. 1073-1075(3)

Delivery of Botox^® by iontophoresis
pp. 1075-1075(1)

Delivery of Botox^® by iontophoresis: reply from authors
pp. 1076-1076(1)

Five cases of cutaneous leishmaniasis in Cambridge, U.K.
pp. 1076-1078(3)

Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up
pp. 1078-1080(3)

Antiepiligrin cicatricial pemphigoid without mucous membrane involvement
pp. 1080-1081(2)